Mark Mallon

Executive Senior Advisor, Ironwood Pharmaceuticals.

Companies

NeoGenomicsBoard member Apr 21, 2021 to Mar 3, 2022¹
NeoGenomicsChief executive officer Apr 21, 2021 to Mar 3, 2022¹
Ironwood PharmaceuticalsBoard member Apr 3, 2019 to Mar 2, 2021²
Ironwood PharmaceuticalsChief executive officer Apr 3, 2019 to Mar 2, 2021²
Ironwood PharmaceuticalsExecutive Senior Advisor Jan 11, 2019 to Jan 11, 2019³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARNeoGenomics, Board member
2
SEC EDGARIronwood Pharmaceuticals, Board member
3
SEC EDGARIronwood Pharmaceuticals, Executive Senior Advisor